BRIEF-Larimar Therapeutics announces regulatory update call on Nomlabofusp Program

Reuters
21 Jun
BRIEF-Larimar <a href="https://laohu8.com/S/LENZ">Therapeutics</a> announces regulatory update call on Nomlabofusp Program

June 20 (Reuters) - Larimar Therapeutics Inc LRMR.O:

  • LARIMAR THERAPEUTICS ANNOUNCES REGULATORY UPDATE CALL ON THE NOMLABOFUSP PROGRAM FOR THE TREATMENT OF FRIEDREICH’S ATAXIA

Source text: ID:nGNX6N6lcJ

Further company coverage: LRMR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10